Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Receivables - Other: 2024

  • Collegium Pharmaceutical's Receivables - Other was N/A to $25.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $25.0 million, marking a year-over-year change of. This contributed to the annual value of $25.0 million for FY2024, which is N/A change from last year.
  • As of Q4 2024, Collegium Pharmaceutical's Receivables - Other stood at $25.0 million.
  • Over the past 5 years, Collegium Pharmaceutical's Receivables - Other peaked at $25.0 million during Q4 2024, and registered a low of $25.0 million during Q4 2024.
  • Over the past 1 years, Collegium Pharmaceutical's median Receivables - Other value was $25.0 million (recorded in 2024), while the average stood at $25.0 million.